Evaluation of a Lopinavir/Ritonavir Monotherapy vs a Triple Therapy as Maintenance Regimens in HIV-1 Infected Patients
Status:
Completed
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
A 2-year multicenter, phase II/III, randomized active-controlled trial to evaluate the
efficacy and tolerance of two maintenance strategies in HIV-1 infected patients with HIV RNA
below 50 copies/mL : a monotherapy with lopinavir/ritonavir or a single-tablet triple therapy
(EFV/FTC/TDF).
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
French National Agency for Research on AIDS and Viral Hepatitis